Dr. Tess Lawrie Urging Health Professionals to Consider this Generic Repurposed Drug for COVID-19

Dr. Tess Lawrie Urging Health Professionals to Consider this Generic Repurposed Drug for COVID-19

Dr. Tess Lawrie, Director of the Evidence-Based Medicine Consultancy Ltd., urges health professionals across the world to evaluate the evidence on ivermectin for prophylaxis and treatment of covid-19. They deserve to have effective tools available to offer their patients the best care possible.  Lawrie has played a key role in the development of a comprehensive meta-analysis tracking dozens of studies around the world.  She was instrumental in organizing the British Ivermectin Recommendation Development (BIRD) panel, which included dozens of multinational scientists and doctors discussing the mounting data points and evidence supporting the use of ivermectin for COVID-19 cases.  Lawrie and ivermectin proponents have faced an increasingly uphill effort as the predominant healthcare organizations and authorities, from the World Health Organization (WHO) to the European Medicines Agency (EMA) to the U.S. Food and Drug Administration (FDA) all call for more data to support any positive recommendation other than for research.

Dr Lawrie recently issued an appeal to physicians to examine the mountains of data themselves as to what she considers the clear benefits of this economical generic drug and decide for themselves whether to recommend it. Follow the link to learn more about this point of view. www.ivmmeta.com and www.covid19criticalcare.com and www.e-bmc.co.uk 

Please see the link to view Dr. Lawrie’s message:  https://vimeo.com/534407694/9f4bc25186.

Responses